HSL-IN-3
CAS No. 346656-34-6
HSL-IN-3( Ethyl 2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzoate | HSL inhibitor 3 )
Catalog No. M26251 CAS No. 346656-34-6
HSL-IN-3 is a boronic acid derivative that is an inhibitor of hormone-sensitive lipase(HSL).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 27 | In Stock |
|
10MG | 38 | In Stock |
|
50MG | 50 | In Stock |
|
100MG | 73 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHSL-IN-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionHSL-IN-3 is a boronic acid derivative that is an inhibitor of hormone-sensitive lipase(HSL).
-
DescriptionHSL-IN-3 is a boronic acid derivative that is an inhibitor of hormone-sensitive lipase(HSL).
-
In Vitro——
-
In Vivo——
-
SynonymsEthyl 2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzoate | HSL inhibitor 3
-
PathwayOthers
-
TargetOther Targets
-
RecptorPEGs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number346656-34-6
-
Formula Weight262.11
-
Molecular FormulaC14H19BO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (381.52 mM)
-
SMILESCCOC(=O)c1ccccc1B1OCC(C)(C)CO1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Snaebjornsson MT, et al. Non-canonical functions of enzymes facilitate cross-talk between cell metabolic and regulatory pathways. Exp Mol Med. 2018 Apr 16;50(4):34.
molnova catalog
related products
-
Asparagusic acid
Asparagusic acid is unique to asparagus. It is responsible for the odorous urine excreted after eating asparagus. Its derivatives ihydroasparagusic acid have an anti-inflammatory effect.
-
Pyropheophorbide-a
Pyropheophorbide-a is a promising photosensitizer for tumor photodynamic therapy (PDT).
-
ICCB280
ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.